company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2889000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2889000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,64000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,98000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2725000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2725000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,1964000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1964000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1964000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-766000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2846000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2846000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,57000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-577000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3341000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3341000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,8491000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13491000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13491000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10141000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7589000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7589000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2693000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1870000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2954000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2954000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5100000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15240000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,19364000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1282000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28231000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28231000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25277000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,81000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10123000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10123000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,98000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4138000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2530000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3351000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3351000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93311000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-93345000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-93345000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,96600000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-9942000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86651000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86651000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10045000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 19:19:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,225000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10385000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10385000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,274000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,907000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1118000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8074000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8074000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9513000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5500000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4107000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4107000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,7000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,264000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-9996000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9942000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,217000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,217000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11964000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,337000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19025000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19025000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,273000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5875000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4145000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17006000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17006000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-508000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27504000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26907000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26907000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,123000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,65021000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,65144000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,65144000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75045000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,338000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20002000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20002000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,425000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,811000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4275000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14476000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14476000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52459000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6749000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45714000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45714000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,297000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,297000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59893000.0
"Auspex Pharmaceuticals, Inc.",ASPX,,0001454189,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,337000.0
